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The clinical efficacy of rcrinoids in benign and malignant 
skin diseases involving immune mechanisms suggests that 
they affect the im munologic functions of the epidermis. 
However. these e.ffects have yet co be demonstrated. The 
action of vitamin A (retinol) and the synthetic rerinoids, 
isorretinoin. crrcrinarc, ac.irrerLn, and arotinoid-free acid have 
been studied on rhe lymphocyte proliferation induced by 
phytohemagglutinin (PHA), by the mixed lymphocyte reac-
tion (MLR), and rhe mixed epidermal cell-lymphocyte reac-
tion (MECLR). The results for PHA-induced.rroliferations 
were highly variable for all the retinoids. However, in 
MECLR, the synthetic rctinoids consistently reduced the 
proliferation by 20% - 30%. This occurred at therapeutic 
drug concentrations of about 10-7M. In MLR, a minor de-
crease af 10% - 15% was only found far higher cancentra-
V itamin A derivatives (i.e .. retinoids) have beneficial effects not only 011 skin diseases with abnormal epi-dermal proliferation and differentiation such as psori-asis or ich thyosis, but aJso on diseases involving ab-normal interactions between lymphocytes and 
epidermis (e.g., lichen pLanus or cutaneous T -cell lymphoma) [1 .2]. 
This implies that they might alter immune skin functions. In fact, 
rerinoids have been shown to act an most components of the im-
mum' systcm such as T and B lymphocytes and macrophages. Reti-
noids can either enhance or decrease phytohemagglutinin (PHA)-
induced T-cell proliferations, depending on the retinoids used, and 
their concentrations [3,4]' Most studies suggest that, in vivo, reti-
noids rather enhance T -cdl functions such as delayed-rype hyper-
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Ahhn'vi:ttiom: 
CRABP: ce llular retinoic acid bindin g prote in 
CTL: cytotoxic T lymphocyte 
DMSO: dimethylsulfoxide 
IL-I : interleukin-l 
MEC LR: mixed epidermal cell-lymphocyte reaction 
MLR: mi xed lymphocyte reacrion 
MIT: 3-(4,S-di111crhylthiazol-2-yl)-2.S-diphenyl tetT:l.zolium 
bromide 
PDMC: ~ripheT:l.I blood mononuclear cell 
PH A: phytohemagglutinin 
[ions (10- SM) . Retinol induced no effect in either reaction. 
Further analysis of acitretin on MECLR showed that it re-
duced lymphocyte proliferation in a dose-dependent fashion. 
This reduction was combined with a decrease in cytotOxic 
T-Iymphocyte induction (CTL). Addition oflO--M acitretin 
at various times also revealed that its presence at cell culture 
initiation was necessary to inhibit proliferation signi£cantly. 
Furthermore, cell treatments prior to MECLR showed that 
exposure of epidermal cells to acitretin was essential to pro-
duce this inhibition, suggesting that it acts directly on cpi-
dennal cells. Consequently, it is suggested that the specific 
inhibitory effect of synthetic tetinoids on lymphocyteactiva-
tion in MECLR may partly account for their therapeutic 
action on the skin. J Irlllest Dermatol 93:455 -459, 1989 
sensitivity 1.5]. skin allograft rejection [6]. and antitumoral immu-
nity in mice [7]. However, delayed-type hypersensitivity reaction 
also can be inh ibited if retinoids are given during the sensitization 
phase [8]. Contradictory data have been reported concerning mac-
rophage, [9]. 
The immunologic properties of the skin are now well docu-
mented. Epidermal Langerhans cells are dendritic bone marrow-de-
ri ved ceUs that synthesize and express class II histocompatibility 
antigens (e.g., HLA-DR) 110). They are effective antigen-present-
ing cells in allogeneic and antigen specific proliferation and in cyto-
toxic T-cell responses. Like macrophages. they produce inter leu-
kin-l (IL-l ). Keratinocytes aJso secrete soluble factors that may 
enhance or inhibit T -cell proliferation and differentiation, includ-
ing IL-I [II]. th ymopO"ietin [12]. and prostaglandins [13]. On the 
other hand, lymphocytes may also affecr the epidermis. For in-
stance, the Iymphokine interferon-/' induces HLA-DR expression 
by keratinocytes [14]. In short , although epidermal ceUs and lym-
phocytes are known to influence each or her's proliferation and dif-
ferentiation via cellulat and soluble factors, nothing is known about 
the modulation of these factors by the rerinoids . The mixed epider-
mal ce ll-lymphocyte reaction (MECLR) is a well-defined reaction 
in which epidermal cells strongly stimulate proliferation of allo-
gem'ic lymphocytes. This reaction was recently shown to be a reli-
able predictive model in graft-versus-host disease. which involves 
epidermal cell-lymphocyte interactions 115J. Tberefore, MECLR 
appears to be a useful tool for studying pharmacologic modulation 
in cutaneous immune reactions. 
1n rhe present work, we investigated the action of rerinoids on the 
immunologic functions of the epidermis. For this purpose. we stud-
ied the effects of retinol and synthetic analogues upon the MECLR 
in humans. We demonstrated that vitamin A derivatives specifically 
inhibit the lymphocyte activation by allogeneic epidermal cells. 
Furthermore, the observation that the inhibition of the MECLR by 
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rcrinoids requires either early addition of the drugs eo rhe cultures or 
pretreatment of the epidermal cells. suggests that rerinoids act di-
recdy on the antigen presenting properties of these cells. 
MATERIALS AND METHODS 
Materials Sixteen healthy adult volunteers (ten men and six 
women) were recruited with rhe agreement of the hospital ethics 
committee. Their ages ranged from 18 to 39 years, with a mean age 
of26. 
Peripheral blood mononuclear cells (PBMC) were isolated from 
heparinized venous blood samples by centrifugation over Ficoll Hy-
paque densiry gradients (Eurobio, Paris, France). Epidermal sheers 
were obtained from suction blister roofs on thigh skin. Each blister 
was removed with scissors and washed in McKeehan 's solution 
(Flow Laboratories. Irvine. United Kingdom). The sheers were em 
ineo small pieces, incubated in a 0.3% solucion of trypsin for 15 min, 
and again washed in McKeehan's solution. The resulting dispersed 
cells were centrifuged and resuspended in culture medium. Using 
these procedures, we obtained more than 80% of viable epidermal 
cel ls. 
Medium consisted of RPMI 1640 (Flow Laboratories, Irvine, 
Un..ired Kingdom) supplemented with L-giutamine (1 %). nones-
sential amino acids (1 %), penicillin-streptomycin (1 %). HEPES 
buffer (3%). and decomplemented human AB se rum (10%). 
Mole:cules studied were the natural rerinoid re.tinol (Ro 01-5488) 
and four synthetic retinoids: isotretinoin (Ro 04-3780), etrerinate 
(Ro 10-9359), acitretin (Ro 10-1670), and arotinoid-free acid (Ro 
13-7410). These re.rinoids were initially srored in 10% dimethylsul-
foxide (DMSO) at -20°C. Because retinoids afe light-sensitive, 
they were diluted in the medium JUSt before addition to the wells. 
and cul tures were incubated in the dark. Cultures containing similar 
amounts of DMSO only were used as control s. 
CelJ Viabiliry The direcr cytoroxic effects on lymphocytes and 
epidennal cells of various concentrarions of rcrinoids and their 501-
vants (ethanol and DMSO) were checked using tcypan blue exclu-
sion after periods of incubation up to overnight. Further investiga-
tion on cell viabiliry with 10-SM erretin was conducted in [he same 
conditions using 3-(4,5-dimethylrhiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) assays, as described f 16). 
P HA-Induced Lymphocyte Proliferation Assays Lymphoid 
cells (10' Iml) were cul tured with 1 % of PHA in 200-1'1 round-bot-
tomed microtiteJ plates (Corning Glass Works , Corning, NY). The 
tcrinoids and DMSO were put at the ini tiarion of the culrures. The 
cultures were incubated at 37°C for 4 d in a dark chamber contain-
ing , humidified 5% CO, atmosphere. ['H]thymidine (0.8 I'Cil 
well) (CEA, Gif-sur-Yvette, France) was added to cultures 18 h 
before harvesting with a Mash II apparatus. Counts per minute 
(cpm) were determined by an LKB liquid scintillation counter . 
Mixed Lymphocyte R eactions a nd Mixed Epidermal Cell-
Lymphocyte R eactions Allogeneic mixed lymphocyte reactions 
(M.LR) and m.ixed epidermal cdl-Iymphocyte reactions (MECLR) 
proceeded in round-bottomed microrite.r pb.tes by mixing 105 vi2-
ble responder lymphocytes and 105 irradiated (2400 R) stimulator 
allogeneic cells [either peripheral blood mononuc\ear cens (PBMC) 
or epidennal cdls1 in a final volume of200pl. ln both reactions, the 
presence of 105 sti.mulator cells in cul tures was able to up-stimulate 
lymphocyte proliferation, as demonstrated by previous titration ex-
perimenrs 1171. The retinoids were added at culrure initiation. Cul-
tures were set up in quadruplicate. [3HJthymidine incorporation was 
measured for 18 h. after 5 d of culture. In SOme MECLR cultures, 
lO-ttM acitretin was added once on day O. 1, 2. 3, or 4, and in others 
ir was added cumulatively either on days 0, 1, 2, 3, and 4, or on days 
1 and 3. 
In other MECLR cultures, responder lymphocytes and stimulator 
epidermal ce lls were incubated separately with either 10-6M etretin 
or 0.01 % DMSO for either 2 h or overnight, and washed five rimes 
in fresh medium. The two types of cells were then combined as 
either lymphocytes treated with DMSO + epidermal cells treated 
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with DMSO; lymphocytes treated with acitretin + epidermal cells 
treated wirh DMSO; lymphocytes treated with DMSO + 
epidermal cells treated with acit.retin; or lymphocytes treated with 
acitretin + epidermal cells treated with acirreein. 
G eneration of Cytotoxic T Lymphocytes in MEGLR 5· 106 
responder lymphocytes and 5 . 106 allogeneic epidermal cells were 
cultured in 25 cm3 tissue culture flasks containing 10 ml of medium 
in the presence of acitretin (I O-ft or 10-SM). After 6 d of culture, 
responder cells were tested by chromium release on PHA-induced 
ta.rget PBMe, autologous ro the stimulating epidermal cells. The 
cyrotoxicity assay consisred of incubating 100,ul of various concen-
trations of responder cells for 4 b at 37°C with 100,ul of allogeneic 
or control autologous target cells. in sharp bottom-microtiterplates. 
Results were expressed as specific chromium release: 
(~ICr release by responder cells 
- spontaneous Ster release) X 100 
Total amount oPICr incorporation into rarget cells 
- spomaneous ~ICr release 
Statistical Analysis Results were analyzed for sta tistical signi.fi-
cance using the rwo way-analysis of variance, and the Student's 
I-test. 
RESULTS 
Direct Cytotoxiciry of the Retinoids and Their Solvants A 
direcr cytotoxic eftect appeared after a 4-h incubation. After 18 h, 
1 % DMSO or ethanol significantly reduced rhe viabiliry of both 
lymphocytes and epidermal cells (p<0.02) . A more toxic effect was 
observed with 1O-4M retinol , acitrerin or arotinoid-free acid in the 
presence of 1 % DMSO (p<O.O I) } whereas isotrerinoin and erretin-
ate at the same concemrations did nor produce any effect in addi tion 
to that ofDMSO. For up to overnight (- 16 h). cell viabiliry in rhl": 
presence of both 10- sM retinoid and 0.1 % DMSO was about 60% 
of the in.itial concentration, i.e., similar to that observed in control 
medium. except for lO-~M rctinol. which was srill slightly {Oxic on 
lymphocytes (p = 0.08). With 10-6 rerinol. no decrease of lym-
phocyte viability was observed. Additional experime.nts using the 
MIT assays showed again thar IO-SM acirrctin induced no reduc-
tion on lymphocyte and epidermal cell viability, compared with the 
controis (medium, and 0.1 % DMSO) (data not shown). 
Synthetic Retinoids Significantly Decreased tbe Lympho-
cyte P roliferation in MECLR Four indt'pcndt'nt exper.iments 
on the Iymphocyre proliferation induced by PHA. MLR, and 
MECLR were conducted for each retinoid. Figure 1 illustrates the 
comparative results with lO-6M acitrctill. 
At concentrations between lO-ftM and to-SM. etretinate and aci-
rretin tended to inhibit PHA-induced proliferation. The other reti-
noids often exhibited no effect. However, none of these results was 
consistentlyobserved. 
In MLR, isorretinoin, acitrctin and arotinoid-free ac.id onlv inhib-
ited lymphocyte proliferation slightly by 10%- 15%. Moreover, 
this inhibition only occurred at rhc. high c.nncenrr~rion or 10- sM . 
Neither retinol nor ('ereeinate had any inhibitory or stimulamry 
effect. 
In MECLR, the inhibition oflymphocytc proliferation by all the 
rerinoids except retinol was consistentl y higher rhan that observed 
ill MLR. Ardrug concentrations berween 10- SM and 1 0-1M, isotrc-
tinoin, acirrecin, and arotinoid-frce acid reduced [JH]thym.idinc in-
corporation into lymphocy tes. by 20%-30%. In some acitretin-
rreated cultures. addition of 5 . 101 M indomethacin (ClRD, 
Sophia-Antipolis, France). which is known as an inhibitor of prosta-
glandin synthesis, did not lead to a reduction of this inhibition. 
Etretinate induced less inhibition than the other synrhetic rerinoids 
(10% - 20%). At retinoid concentrations of 10--9M, there was no 
difference between proliferation in the retinoid groups and the 
DMSO comrol groups. 
A twO way-analysis of variance was realized on the results ob-
tained with 10--6M retinol and acitrctin, in MLR and MECLR 
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Figure 1. Quadruplicate me2surements oflymphocyte proliferation during 
concinuollS exposure of IO-6M aci tretin in the PHA- induced blast' teSt, 2110-
geneic MLR. and MECLR [rom four subjects providing effector lympho-
cytes (a. b. c, and d). Assay times were 4 d for tht' PHA test' and 6 d each for 
MLR and MECLR. Proliferation was measured by IlH]thymidint' eell incor-
pOr:l.tloll. Results arc expressed .as dIe percentage ot response in cultures 
tre:ated with acitretin versm the response in the corresponding control PHA. 
MLR. and MEC LH cultures exposed to 0.01% OMSO (=100). Error him 
represent mcam. ± SO of the total values in each reacoon. 
(Table I). With retinol (T able IA ), the difference of lymphocyte 
proliferarion berween MLR and MECLR was not statistically sig-
nificam. In contrast, acitretin significantly decreased lymphocyte 
proliferation during MECLR. compared with that during MLR 
(p<O.OOl. Table 1 B). 
Dose.Response C u rves W ith Acitretin in MLR and MEC LR 
To esrablish dose-response curves, lymphocyte proliferation in 
MLR and MECLR was studied in the presence of various concentra-
tions of acitretin. The final concentration of DMSO in each well 
was 0.0 I %. T he results of rwo separare experiments confirmed 
those of the described studies, because inhibition of cell prolifera-
tion was significantly higher in MECLR than in MLR (Fig 2). In 
MECLR. rhe decreast:" in IlH Jthymidine uprake by the lymphocytes 
was clearly dose dependcnr. and reached a plateau of inhibition at 
about 30% for an approxirnare aCltretin concentration of 1 a-1M. 
Acitretio Inhibits the C11.. lnduct ion in ME CLR In rwo sepa-
rate experiments, rhe induction of a cyrotoxic lymphocyte (CTL) 
acrivity in rhe presence of 10--6 and IO- IIM acitrerin was tested in 
MECLR. In this reaction, 10-6M acitrerin signilicanr\y reduced not 
only rhe proliferation bur also CTL activity (Fig 3), whereas no 
Tab le J. Two-Way Analysis of Variance Obtained W ith 
1 0~M Retinol (Aj and Acitrerin (B) in the Four Subject-G roup 
(a. b, c, and d), During MLR and MECLR' 
% comrol % control 
Retinol MLR MECLR Acitretin MLR MECLR 
, 105 95.5 , 91 78.75 
b 96 103 b 94 82 
c 97 95 c 88 74.3 
d 102 98 d 86.5 80 
A F(subj) 1.17. (p - 0.34). 8 F(subj) 2.87. (p - 0.06). 
F(rt';lct) 1.34. (p - 0.26). F(react)42.2S. (p < 0.001). 
F(imer) 3.49. (p - 0.03). F{imer) 0.86. (p - 0.47) . 
• The first folClOr F(lubj) w;u thr individu.:I.Is. and the 5fi:ond F(rcact) the: rnctions 
(MLR and MECLR). An interaction term F(inter) between the:st' rwo Factors was 
systcnutica.lly tested. MLR. mixed lymphocyte melioll; MECLR. mixed epiderm;l] 
eell-lymphocyte re;lction. 
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Figure 2. Effect of v;lrious concentT3tions of acitretin on the prolifer:nive 
lymphocyte response using responder and stimulator cells [rom the same 
subjects in MLR and MECLR. In each wei!. rhe DMSO conccntn.tion was 
0.0 10/0. Results are expressed as percent stimubtion below the contro l level 
of prolifer:nion with 0.1 % DMSO. Concentrations of acitretin on the ab-
scissa arc expressed on a logarithm scale. 
effect was observed when PBMC stimulator cells were used (dara: 
not shown). At 1O-8M. CTL activity during MECLR was wirhin 
normal limits. 
Aci tretin Acts on the Stimula tor E pidermal C ells in 
MECLR The action of aci tretin on lymphocyte activation in 
MECLR was further examined using two sets of experiments. In the 
first set. the respecrive effects of one and several additions of 10'M 
acittetin on the proliferative response were tesred. Addirion of aci-
rretin at the in itiation of culrures (day 0) was crucial fot inducing 
significant inhibition of proliferation (p<0.02, Fig 4). Further addi-
tions. ei ther on days 0, 1, 2, 3, and 4, or on days 0, 2. and 4, did not 
increase inhibition. Addition of acirretin to an ongoing MECLR 
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Figure 3. CTL activity generated by MECLR in the presence of I0-6M 
acitretin (lower (UTVt:') or 0.01 % OMSO (control, UPI>" luror). At ruy 6 of the 
MECLR. responder cells were harvested, washed three times. and then 
incubated with 5lCr_labcled PHA-stimulated allogeneic lymphoid target 
cells in a 4-h assay. EltecfOr-to-targer-ceJl ratios .are indicated. 
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Figure •. Effect of adding 0.0 I % DMSO or 1O-6~ acitrerin on various 
days (D) of culnue, all lymphocyte proliferation durmg MECLR. 
after day 0, either once on day 1,2,3, or 4, or rwice on days 1 and 3. 
did nor induce any difference in proliferation versus the control 
group. 
In the second set of experiments. responder lymphocytes and 
srimuiacof epidermal cells were preincubared before MECLR with 
10' M acitrerin or 0.01% DMSO, as described in Methods. The 
results of three independent experiments with overnight pfeineu. 
baricn (Table II) showed 1) the decrease in lymphocyte p.rolifera-
rion could be reproduced by treating born responder and stimulator 
cells wi th aeletetin ; 2) preincubation of responder cdls alone with 
acittetin did not induce any significant effect; and 3) preincubation 
of stimulator epidermal cells only with aci trecin significantly re-
duced [3HJthymidine incorporation by responder lymphocytes. 
When the pteincubation period was 2 h. no significant effect was 
found, whatever the treatment. 
DISCUSSION 
We have dcmonstratcd that in human MECLR. nontoxic concen-
trations of four synthetic rerinoids significantly inhibited lympho-
cyte proliferation, w hereas the natural product' retinol had no effect. 
Inhibi tion of lymphocyte proliferation was combined with a de-
crease of CTL activity induction. It occurred at an early stage in cell 
culture and mainly affected 5timulator epidermal cells. 
Laboratory experiments have confirmed thar retinoids act on 
most components of the immune system, including T lymphocytes 
[9]. Retinoids regulate either up or down T -eel! functions, depend-
ing on the experimental conditions. Thus, proliferation of human T 
cells induced by PHA was i_nhibited in vitro by retinol [18]. isotre-
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tinoin 119], ctrctinate and acitretin 14 ,201, bm was stimulated by 
retinoie acid in vitro [3] and isocrctinoin in vivo 121]. Similarly, in 
the MLR. retinoic acid reduced bovine lymphocyte proliferation 
[221 bue, in vivo, rctinyl ester prevented the suppression of the MLR 
nonnally found in patients after surgery {23]. Data. concerning the 
effects of retinoids on human MLR are not presently available, In 
bric{ rctinoids seem ro display bifunctional activiry that makes their 
usual beneficial effects 011 cuta.neous immune reactions difficult to 
explain. Dosage problems may account for these discrepant results . 
Our kinetic study of cell viabiliry using trypan blue exclusion 
clearly showed thar rerinoids and their solvants (DMSO and eth-
anol) werC' direcdy cytotoxic at concentrations above 1O-!iM and 
0. 1 %, respectively. This toxicity probably partially explains the 
inhibitory in vitro effecr of rctinoids on lymphocyte proliferation 
reported by some authors [18-20. 22, 24J. 
On the other hand, we confirmed that the effects of retinoids on 
PH A-induced proliferations are variable, Noncytotoxic concentra-
tions of etretinate and more especially, acitrerin, had rather inhibi-
tory effects as recently reported by Shetbany and co-workers [4J. 
H owever. tbese effects wcre not consistent. Thus: nonspecific 
PHA-induced proliferation does nor allow clear appreciation of rhe 
pharmacologic action of rcrinoids on T lymphocytes. 
Allogeneic reactions induct" a well-defined lymphocyte acri\'a-
rion, including primary T-cell proliferation and induction of CTL 
activity in response to speci fic alloantigens. In these reactions, den-
driric Langerham cells in MECLR on the one hand, and PBMC of 
the macrophagic lineage on the othet , a.re essential for antigen pre-
senrJrion [25 J. Our resul ts provide compelling evidence rhat, excepr 
for retinol, thl." rl."tinoids testcd specifically modulate lymphocyre 
activation in MECLR for three reasons: 1) the synthr:tic rcrinoids 
significantly inhibited proliferation in a dose-dependell[ fasbion 
with acitretin: 2) this inhibition was combined witb a decreased 
induction of CTL activ ity; and 3) unlike what occurred in MECLR. 
little or no effect was observed on PHA-induced proliferation and 
011 proliferation during MLR. 
lnMECLR. acitrerin significantly inhibited lymphocyte prolifer-
ation by abom 30%, at doses within the rherapcutic range. i.c .. 10' 
to 1 Q-'M. Irs action on epidermal cells was crucial fo r inducing th_is 
inhibition. As we did nOf perform modulation stud.ies using purified 
or Langerhans cell-enriched epidermal cell cultures, the mechanism 
of action by which synthetic rerinoids act on epidermal cells remains 
to be dete rmined. It is known that an inc.reased expression of la 
antigens on mouse Langerhans cell is associated with an enhanced 
capacity of antigen presentation by rhest" cells [26]. Some immune-
regulatory cywkines such as IL-l {1l], interleukin-6 127], inter-
feron [281, prosraglandin-E2 [131. and transforming growth factor-p 
1291, arc. also known to be syn thesized by eridermal cells, wbereas 
others have not yet been characterized [30 . Thus. severa l mecha-
nisms can be proposed to explain the retinoid action 011 rhe immu-
nologic functions of epidermal ce ll s. Retinoids regulate protein bio-
syn thesis via a specific nuclear retinoic acid-receptor 131 J. They also 
act on protein glycosylation [32]. Although acitrctin did not appear 
to alter HLA-DR expression by epidermal cdl suspensions using 
indirect inunullofluorescence techniques (data not shown), acitretiu 
might direcrly imer\'ene via these mechanisms on the antigen 
presenting functions of Langethans cells, for instance by altering 
Table n. Effects of Cell Treatments with Acitretin on Subsequent MECLR 
Exp. 1 
Exp. 2 
Exp. J 
LV (D MSO) 
+EC (DMSO) 
73452 ± 5210 
32840 ± 3824 
39749 + 3060 
MECLR Conditions 
L Y (Acitretin) 
+ EC (Aeitrctin) 
59657 ± 4118 
22689 ± 5039 
30764 + 3258 
L Y (Aeitrc:tin) 
+EC(DMSO) 
69358 ± 2014 
28673 ± 3683 
42100 ± 641 6 
LV (DMSO) 
+EC (Acitrctin) 
60859 ± 3743 (p < 0.01) 
2581 4 ± 2850 (p - 0.05) 
31429 ± 4557 (p < 0.05) 
• CeJl ueatmen~ with J()-6M lduetin VI expo$urt' to 0.01% DMSO (conrrol) before MECLR, in three- independent experiments. Responder lymphocytes [L V (DMSO) or LV 
(Acitretin)J :md scimulJrofepiciennal cells {EC (DMSO) or EC (Acirrecin)! weretrelted sepan.tdy overnig ht. Afterwards. ceJl$ werE' wa.Jhed fivE' rimes. lnd culturcd in the MECLR 
system. Values repment mean {JHJthymidme incorporation ± SD. P values are given for DMSO-trcated L Y prolifentions with acitretin-trcated EC comp:ucd to those with 
DMSO-treatcd Ee. 
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their HLA-DR antigen production. It might also act through the 
accessory functions of epidermal cell s, by modulating the produc-
tion of the cytok.ines quoted above. The retinoid effects on prosta-
glandin -E:;! seem unlikely because here the prostaglandin inhibitor, 
indomcthacin, had no action on the aeitretin inhibition. Alterna-
tively, rctinoids migh t also act directly on epidermal cell mem-
branes. 
It is noteworthy that, in our da ta. rctinoids with a free carboxyl 
group in the CIS position significantl y inhibited the MECLR, 
whereas retinol and enctinate, which respectively have an alcohol 
and a dimethylethylesrer function in this position, induced a weaker 
or nonsignificant action. Because the availabiliry of this free car-
boxyl function is a necessary condition for binding to the cellular 
retinoic acid binding protein (CRABP) [33], this latter might medi-
ate the effects of active rctinoids on epidermal cells during MECLR. 
T hus, the predominance of CRABP in epidermal cel ls may explain 
in pan the specific action of rhe syntheric rcrinoids in MECLR [34]. 
We observed that the synthetic analogues of vitamin A had a 
spec ific action in MECLR, whereas retinol did not. New active 
derivatives such as aci tretin . the main metabolite of etrctinace, and 
arotinoid-free- acid induced a greater inhibition [han already com-
mercialized rcrinoids- such as isotretinoin and errecmate. MECLR 
might therefore be a useful cool for assessing the in vitro immuno-
logic action of new molecules. However. it remains to be estab-
lished that the down-mod ulation by rctinoids of lymphocyte acti-
va tion, and the magnitude of th is regulation in vitro refleer the 
situation in vivo. The changes caused by retinoids in th e- interaction 
between epidermal cel ls and lymphocytes may partly explain their 
the rapeutic effects on the skin. 
Wt' would likr fDadmol4lledgl' tlrr Ir tlpofDr. T. HartmtHl n f rom Hoffmamr-LArorht 
Lab(jralOri~s, UINO kindly supplied th~ relinoid stJ mp/~s, and Dr. C. Chasllmgfor 
statistiral t1Iralysis. 
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